Vaxil BioTherapeutics, a biotechnical company based in Ness Ziona, near Tel Aviv, Israel has produced a ground-breaking therapeutic vaccine for cancer patients which could prevent about 90 percent of cancers from coming back.
Vaxil was founded in 2006 by Dr. Lior Carmon and the vaccine is now in clinical trials at the Hadassah University Medical Centre in Jerusalem. The vaccine could be available as early as 2017 to administer on a regular basis, not only to help treat cancer but in order to keep the disease from recurring.
Soroka hospital and Ben Gurion University in Be’er Sheva, Israel, are developing a unique method to detect various types of cancer through a simple blood test.
Researchers say that in a first trial conducted recently, they succeeded in detecting cancer in almost 90 percent of cancer patients tested.
